Royal Olympic Hotel, Athens, 30- 31/03/2018

IASIS PHARMA participated with great success as a Main Sponsor in the 23rd Greek Conference for Helicobacter pylori and Other Infections of the Digestive Tract. The conference was co-organized by the Greek Society for the Study of H. pylori (E.E.M.E.P.) and the Hellenic Society for Infectious Diseases.

ΙΑSIS PHARMA focused its active participation in the event on mastihatherapy® caps, a unique natural traditional herbal medicinal product. Each capsule contains 350mg of pure Chios Mastic(Pistacia lentiscus L. resin) recommended for the treatment of functional dyspepsia. Medical professionals were highly interested on this herbal medicine, known to humanity since 2.500 b.c., with several reports from the ancient times but also many contemporary published scientific studies.

IASIS PHARMA is the only pharmaceutical company that is supplied with pure Chios Mastic directly from Chios Mastic Growers Association (C.M.G.A), ensuring the quality and originality of mastihatherapy® caps, available only through pharmacies, in packs of 30 or 90 capsules.

Worth mentioning was a lecture by Dr. Zavos’, a specialized Gastroenterologist –Hepatologist, which created a lot of interest among the participating specialists. In his lecture, under the title “Chios Mastic and alternative helicobacter pylori therapies. Modern aspects”, Dr. Zavos cited 5 medical studies that were carried out with Chios Mastic as the active ingredient under investigation, all of which give positive and encouraging results for the use of Pistacia lentiscus L. resin as an add on therapy to the standard antibiotic treatment for the eradication of H. pylori.